Netherlands· NL-101fa2182566
Orladeyo 72 mg filmomhuld granulaat in sachet
A berotralstat product containing berotralstatdihydrochloride, registered in Netherlands by BioCryst Ireland Limited. The same ATC class is registered in 17 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Berotralstat is registered in 17 of 19 countries.
Countries holding a registration under ATC B06AC06 (berotralstat), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 11 of them publish a price we can compare per daily dose
Berotralstat · ATC B06AC06
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of berotralstat costs, country by country.
Normalised to the WHO defined daily dose (0.15 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Berotralstat · price per daily dose (0.15 g)
USD · FX 28 Sept 2026
- CH Switzerland$576.89
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- BEROTRALSTATDIHYDROCHLORIDE
- Manufacturer
- BioCryst Ireland Limited
- Country
- Netherlands (NL)
- ATC code
- B06AC06
- ATC class
- Berotralstat
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/21/1544
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
209 interactions on record for berotralstat.
Graded by severity as the source publishes them — 66 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Berotralstat · interactions on record
209 records
- 66 severe
- 132 moderate
- 11 minor
Most severe, free to view
- RolapitantA04AD14severe
- NaloxegolA06AH03severe
- FidaxomicinA07AA12severe
- EliglustatA16AX10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Berotralstat in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumOrladeyo 72 mgBiocryst Ireland
- CzechiaORLADEYOBIOCRYST IRELAND LIMITED, Dublin
- FinlandOrladeyoBioCryst Ireland Limited
- SwedenOrladeyo 72 mg Filmdragerat granulat i dospåseBioCryst Ireland Limited
- United StatesOrladeyoBioCryst Pharmaceuticals, Inc.
- FranceORLADEYO 150 mg, géluleBIOCRYST IRELAND LIMITED (IRLANDE)
- United KingdomOrladeyo 150mg capsulesBioCryst Ireland Ltd
- IrelandOrladeyo 150 mg hard capsulesBioCryst Ireland Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Orladeyo
- Liechtenstein · Orladeyo
- Norway · Orladeyo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/59293ba7-ca58-447c-8880-500d6e2e528a GET /v1/drugs/59293ba7-ca58-447c-8880-500d6e2e528a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhuld granulaat",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/orladeyo-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Berotralstat",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp135279",
"excipients": [
"BASISCH GEBUTYLEERD METHACRYLAAT COPOLYMEER (E 1205)",
"CROSPOVIDON TYPE A",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL, GEPREGELATINEERD",
"NATRIUMLAURILSULFAAT",
"SILICIUMDIOXIDE (E 551)",
"STEARINEZUUR (E 570)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"BEROTRALSTATDIHYDROCHLORIDE"
],
"leaflet_url": null,
"authorised_at": "2021/04/23",
"procedure_number": "EMEA/H/C/005138",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/21/1544",
"additional_monitoring": "N"
}See everything about berotralstat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.